Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 single-arm open-label multicenter study of human prothrombin complex for hemophilia B
CTR20253213Phase 3Completed
- Sponsor
- Wuhan Institute of Biological Products
- Start
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of prothrombin complex concentrate, human in hemophilia B (HB), sponsored by Wuhan Institute of Biological Products. Started Oct 2025; status: completed.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20253213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253213.